Whole-body MRI for preventive health screening:A systematic review of the literature by Kwee, Robert M. & Kwee, Thomas C.
  
 University of Groningen
Whole-body MRI for preventive health screening
Kwee, Robert M.; Kwee, Thomas C.
Published in:
Journal of Magnetic Resonance Imaging
DOI:
10.1002/jmri.26736
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Kwee, R. M., & Kwee, T. C. (2019). Whole-body MRI for preventive health screening: A systematic review
of the literature. Journal of Magnetic Resonance Imaging, 50(5), 1489-1503.
https://doi.org/10.1002/jmri.26736
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 11-12-2019
ORIGINAL RESEARCH
Whole-Body MRI for Preventive Health
Screening: A Systematic Review
of the Literature
Robert M. Kwee, MD, PhD,1 and Thomas C. Kwee, MD, PhD2*
Background: The yield of whole-body MRI for preventive health screening is currently not completely clear.
Purpose: To systematically review the prevalence of whole-body MRI ﬁndings in asymptomatic subjects.
Study Type: Systematic review and meta-analysis.
Subjects: MEDLINE and Embase were searched for original studies reporting whole-body MRI ﬁndings in asymptomatic adults
without known disease, syndrome, or genetic mutation. Twelve studies, comprising 5373 asymptomatic subjects, were included.
Field Strength/Sequence: 1.5T or 3.0T, whole-body MRI.
Assessment: The whole-body MRI literature ﬁndings were extracted and reviewed by two radiologists in consensus for
designation as either critical or indeterminate incidental ﬁnding.
Statistical Tests: Data were pooled using a random effects model on the assumption that most subjects had ≤1 critical or
indeterminate incidental ﬁnding. Heterogeneity was assessed by the I2 statistic.
Results: Pooled prevalences of critical and indeterminate incidental ﬁndings together and separately were 32.1% (95%
conﬁdence interval [CI]: 18.3%, 50.1%), 13.4% (95% CI: 9.0%, 19.5%), and 13.9% (95% CI: 5.4%, 31.3%), respectively. There
was substantial between-study heterogeneity (I2 = 95.6–99.1). Pooled prevalence of critical and indeterminate incidental
ﬁndings together was signiﬁcantly higher in studies that included (cardio)vascular and/or colon MRI compared with studies
that did not (49.7% [95% CI, 26.7%, 72.9%] vs. 23.0% [95% CI, 5.5%, 60.3%], P < 0.001). Pooled proportion of reported
veriﬁed critical and indeterminate incidental ﬁndings was 12.6% (95% CI: 3.2%, 38.8%). Six studies reported false-positive
ﬁndings, yielding a pooled proportion of 16.0% (95% CI: 1.9%, 65.8%). None of the included studies reported long-term
(>5-year) veriﬁcation of negative ﬁndings. Only one study reported false-negative ﬁndings, with a proportion of 2.0%.
Data Conclusion: Prevalence of critical and indeterminate incidental whole-body MRI ﬁndings in asymptomatic subjects is
overall substantial and with variability dependent to some degree on the protocol. Veriﬁcation data are lacking. The pro-
portion of false-positive ﬁndings appears to be substantial.
Level of Evidence: 4
Technical Efﬁcacy: Stage 3
J. MAGN. RESON. IMAGING 2019;50:1489–1503.
THE AIM OF PREVENTIVE MEDICINE is to preventthe occurrence or halting of disease and averting resulting
complications.1 With a general increase in health awareness and
a desire to live longer and healthier,2–4 a greater utilization of
preventive medicine measures can be expected. The lack of
ionizing radiation makes magnetic resonance imaging (MRI)
attractive for whole-body screening, aiming at the detection of
disease before its symptomatic manifestation.5 Early detection of
malignant diseases (such as brain malignancies, lung carcinoma,
hepatic malignancies, renal cancer, colonic cancer, lymphoma,
and bone and soft-tissue tumors) or cardiovascular diseases (such
as aneurysms) may have a positive impact on the prognosis. In
countries such as Canada, Germany, Japan, and the UK, whole-
body MRI is offered by private companies for health check-up.
However, in the Netherlands it is forbidden by law to date,
because of uncertainty about the beneﬁt and harms. Some
asymptomatic subjects may beneﬁt from timely intervention or
treatment of early detected critical ﬁndings. However, discovery
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of indeterminate incidental ﬁndings (ie, ﬁndings for which the
effectiveness of intervention or treatment is unknown) and false-
positive ﬁndings (ie, ﬁndings which eventually prove to be
benign) can lead to unnecessary additional examinations, inter-
vention, and treatment, with the associated risk of complications
and costs. Moreover, knowledge of the existence of a critical
ﬁnding for which no preventive or positive action can be taken,
or informing a patient about the presence of an indeterminate
incidental ﬁnding, can negatively affect psychological quality of
life.6 In addition, a false-negative ﬁnding may lead to false reas-
surance.7 To our knowledge, the ﬁrst studies on whole-body
MRI for preventive screening were published in 2005.5,8 In
order to get an up-to-date insight into the yield of whole-body
MRI for preventive health screening, it was our objective to sys-




A computer-aided search of the MEDLINE and Embase databases
was conducted to ﬁnd original articles reporting whole-body MRI
ﬁndings in symptomatic adult subjects without known disease, syn-
drome, or genetic mutation. The following search terms were used:
(whole-body OR WB OR full-body) AND ((magnetic AND reso-
nance) OR (MR AND imaging) OR MRI)) AND ((asymptomatic
OR healthy OR symptom-free OR volunteers OR controls OR
population-based OR (general AND population) OR screening OR
(health AND check)). No beginning date limit was used. The search
was updated until December 14, 2018. To expand our search, bibli-
ographies of studies that ﬁnally remained after the selection process
were screened for potentially suitable references.
Study Selection
Original studies reporting whole-body MRI ﬁndings in asymptom-
atic adult subjects without known disease, syndrome, or genetic
mutation were eligible for inclusion. There was no language
restriction. Only studies that included at least the head, neck, chest,
and abdomen (ie, cranial vertex to groin) in the ﬁeld-of-view (FOV)
were included. Studies that only imaged or analyzed selected body
parts (such as the cardiovascular or musculoskeletal system) and
studies that only analyzed selected, predeﬁned ﬁndings (such as
white matter lesions or liver steatosis) were excluded. Case reports
were also excluded. When data were presented in more than one
article, the article with the largest number of patients was chosen.
With use of the aforementioned inclusion and exclusion criteria,
titles and abstracts of the retrieved studies were reviewed. Articles
were rejected if they were clearly ineligible. The full-text version of
each study that was potentially eligible for inclusion was retrieved.
Full-text articles were then reviewed to deﬁnitively determine if the
study was eligible for inclusion.
Study Data Extraction
Data were extracted by one radiologist with 12 years of experience
in data extraction for systematic reviews (R.M.K.). Data on study
characteristics that might affect risk of bias were also extracted
(Table 1). All whole-body MRI ﬁndings, except predeﬁned pre-
sumed benign ﬁndings (Table 2), were extracted. Descriptions of all
extracted whole-body MRI ﬁndings were reviewed in consensus by
two radiologists (R.M.K. and T.C.K., each with 12 years of clinical
experience) for designation as either critical ﬁnding or indeterminate
incidental ﬁnding. Critical ﬁndings were deﬁned as ﬁndings that
could result in mortality or considerable morbidity if they were not
appropriately treated.9 Indeterminate incidental ﬁndings were
deﬁned as ﬁndings for which the effectiveness of intervention or
treatment was unknown.10 The number of critical and indeterminate
incidental ﬁndings veriﬁed by additional examinations, resection, or
follow-up were extracted. Furthermore, all reported true positives (ie,
critical or indeterminate incidental ﬁndings conﬁrmed by additional
examinations, resection, or follow-up), false positives (ie, critical or
indeterminate incidental ﬁndings eventually found to be a benign
ﬁnding), and false-negative ﬁndings (ie, discovery of critical or inde-
terminate incidental ﬁndings on additional examinations, after resec-
tion, or follow-up) were extracted.
TABLE 2. Predeﬁned Presumed Benign Findings per Body Part
Body part Predeﬁned presumed benign ﬁnding
Head Benign intracranial cysts (arachnoid cysts, pineal gland cysts, choroid plexus cysts, pituitary cysts),
dilated Virchow-Robin spaces
Neck Sinus mucosal thickening or retention cysts, nasopharyngeal cysts, simple thyroid cysts
Chest and breast Lung or pleural scars, bronchogenic cysts, pericardiac cysts, breast cysts
Abdomen Benign liver lesions (cysts, hemangiomas, focal nodular hyperplasia), cholecystolithiasis, splenic
hemangioma or cyst, uncomplicated renal cysts, renal angiomyolipoma ≤2 cm,31 adrenal
adenoma, prostatic hyperplasia, uterine myoma, uterine adenomyosis, benign-appearing ovarian
cysts, colonic diverticuli, hydrocele
Musculoskeletal Degenerative spinal disease, scoliosis, spondylolisthesis, perineural cysts, sacral meningocele, osteoarthritic
joint changes, subacromial bursitis, Baker’s cysts, benign-appearing bone or soft tissue lesions
Other Benign anatomic variants (azygos lobe, unilateral renal agenesis, vascular anatomic variants)
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Statistical Analyses
Statistical analyses were performed using Comprehensive Meta-Analy-
sis, v. 3.0 (Biostat, Englewood, NJ). Data were pooled using a random
effects model. The majority of the included studies only reported the
total number of critical or indeterminate incidental ﬁndings, without
mentioning the number of subjects in whom these ﬁndings were
observed. Prevalence was pooled on the assumption that most
included subjects had no more than one critical or indeterminate inci-
dental ﬁnding. In three studies,5,11,12 reported cardiac abnormalities
(such as infarction and myocardial dysfunction) (Table 3) may overlap
in one subject. Therefore, only the cardiac abnormality with the
highest prevalence was used for the pooled analysis.
The proportion of critical and indeterminate incidental ﬁndings
veriﬁed by additional examinations, resection, or follow-up was
pooled. Proportions of reported false positive (ie, number of reported
false-positive ﬁndings divided by number of all critical and indetermi-
nate incidental ﬁndings) and false-negative ﬁndings (ie, number of
reported false-negative ﬁndings divided by number of all subjects
without critical or indeterminate incidental ﬁndings) were also pooled,
if there were data from at least three studies. Heterogeneity between
studies was assessed by calculating the I2 statistic,13 which ranges from
0 (no heterogeneity) to 100% (all variance due to heterogeneity). Sub-
stantial heterogeneity was deﬁned as I2 > 50%. Potential sources for
heterogeneity were explored by subgroup analyses. Covariates were
publication year (published in or after vs. published before 2014
[2014 was the median]), study size (>174 vs. <174 subjects [174 was
the median]), and additional use of (cardio)vascular or colon MRI.
P < 0.05 was considered a statistically signiﬁcant result for all analyses.
Results
Literature Search
The study selection process is displayed in Fig. 1. Reviewing
titles and abstracts of the MEDLINE and Embase databases
resulted in 19 studies that were potentially eligible for
inclusion.5,8,11,12,14–28 After reviewing the full text, ﬁve studies
were excluded because data were also used in another article
from the same group, comprising a larger number of
patients8,18,25,27,28; one study was excluded because it only
reported study rationale and design,22 and one study was
excluded because it was not clear whether the head and neck
region was included in the FOV.22 Eventually, 12 studies were
included in this systematic review, published between 2005
and 2018.5,11,12,14–17,19–21,23,26 Screening the reference lists of
these articles did not result in other potentially relevant studies.
The principal characteristics of the included studies are pres-
ented in Table 4. A standard whole-body MRI protocol typi-
cally included conventional T1-weighted and fat-suppressed
T2-weighted sequences, without the use of gadolinium chelate-
enhanced sequences. Some of the included studies obtained
additional diffusion-weighted images and some of the included
studies performed additional (cardio)vascular or colon MRI.
Study Quality
Data on study characteristics that might affect risk of bias are
displayed in Table 1. The study design was prospective in ﬁve
studies, retrospective in three studies, and in four studies it
was not speciﬁed. In half of the included studies, subjects
were enrolled consecutively; in the other half, it was not spec-
iﬁed whether subjects were enrolled consecutively or ran-
domly. In all but two studies, all subjects were scanned with
an identical whole-body MRI protocol. In the majority of
included studies, whole-body MRI scans were read indepen-
dently by two or more interpreters and discrepancies were
resolved in consensus.
FIGURE 1: Flowchart of the study selection process. *One potentially relevant study was found in the MEDLINE database but not in
the Embase database,11 the other 19 potentially relevant studies were found in both databases.
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Prevalence of Whole-Body MRI Findings and
Reported False Positives
The median number of subjects per included study was
174 (range 10–2500). The total sample size comprised of
5373 subjects. Pooled frequency of male subjects was 68.6%
(95% conﬁdence interval [CI]: 59.7%, 76.2%). A detailed
description of critical and indeterminate incidental ﬁndings,
veriﬁed ﬁndings, and reported true-positive, false-positive,
and false-negative ﬁndings per included study is displayed in
Table 3.
Pooled prevalences of critical and indeterminate inci-
dental ﬁndings together and separately were 32.1% (95% CI:
18.3%, 50.1%), 13.4% (95% CI: 9.0%, 19.5%), and 13.9%
(95% CI: 5.4%, 31.3%), respectively. There was substantial
between-study heterogeneity (I2 = 95.6–99.1). Pooled preva-
lence of critical and indeterminate incidental ﬁndings together
was signiﬁcantly higher in studies that included (cardio)vascu-
lar and/or colon MRI in the protocol compared with studies
that did not (49.7% [95% CI, 26.7%, 72.9%] vs. 23.0%
[95% CI, 5.5%, 60.3%], P < 0.001). Prevalence was not sta-
tistically signiﬁcantly different in subgroups according to pub-
lication year and study size (Table 5).
An overview of critical and indeterminate incidental ﬁnd-
ings, reported validated ﬁndings, and true-positive and false-
positive ﬁndings per included study is given in Fig. 2. Pooled
proportion of reported veriﬁed critical and indeterminate inci-
dental ﬁndings was 12.6% (95% CI: 3.2%, 38.8%). False-
positives ﬁndings were reported by six studies,5,12,15–17,26 with
FIGURE 2: Overview of critical and indeterminate incidental ﬁndings, reported veriﬁed ﬁndings, and true-positive and false-positive
ﬁndings per included study.
November 2019 1501
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a pooled proportion of 16.0% (95% CI: 1.9%, 65.8%). None
of the included studies reported long-term (>5 year) veriﬁcation
of negative ﬁndings. Only one study17 performed 3–5-year
follow-up for the majority (64%) of included subjects, by
reviewing any performed radiological work-up, medical records,
and/or telephone interviews: reported proportion of false-
negative ﬁndings was 2.0%.18
Discussion
Our systematic review and meta-analysis demonstrated that
the prevalence of critical and indeterminate incidental ﬁndings
on whole-body MRI in asymptomatic subjects is overall sub-
stantial. Studies including (cardio)vascular and/or colon MRI
had signiﬁcantly more critical and indeterminate incidental
ﬁndings. This is due to the fact that these additional dedicated
MRI protocols are more sensitive than general screening
whole-body MRI for the detection of (cardio)vascular diseases
and colon neoplasms. A substantial proportion of critical and
indeterminate incidental whole-body MRI ﬁndings proved to
be false positive. There was a large number of critical and inde-
terminate incidental ﬁndings without reported veriﬁcation
(Table 3, Fig. 2) and none of the included studies performed
systematic and long-term follow-up to verify whole-body MRI
examinations with negative ﬁndings. Therefore, false-positive
and false-negative ﬁndings may be underreported.
The use of different MRI protocols leads to different sen-
sitivity and speciﬁcity, and this was probably the main cause of
between-study heterogeneity. For example, in one study a coc-
cygeal chordoma was probably not detected because no
sequence in the sagittal plane was acquired.17 In another study,
lung carcinoma was only detected on diffusion-weighted imag-
ing.23 In yet another study,17 gadolinium-enhanced sequences
were used in 12 subjects for lesion characterization, which
increases speciﬁcity (and decreases false-positive ﬁndings).
Because there was a large variation in MRI protocols used by
the included studies, we could not explore the effect of relevant
parameters (such as the use of different imaging planes and
sequences) on the prevalence of whole-body MRI ﬁndings. All
except two studies reported that whole-body MRI was inter-
preted by at least two observers, of which at least one was an
experienced radiologist. Therefore, we believe that interpreter
skill was not a major contributor to between-study heterogene-
ity. Nevertheless, it should be noted that whole-body MRI for
preventive health screening is not widely available yet and radi-
ologists in general may have little experience/skills in inter-
preting whole-body MRI.
Our systematic review had several limitations. First, a
major limitation of our study is that prevalence data were
pooled on the assumption that most included subjects had no
more than one critical or indeterminate incidental ﬁnding.
Second, there is no (inter)national consensus list of critical
and indeterminate incidental ﬁndings.29,30 All extracted
whole-body MRI ﬁndings were reviewed by consensus of two
radiologists based on the available information in the original
studies. Potentially relevant information such as subject’s age
and gender, and exact location, size, and signal characteristics
of detected lesions were not presented for each subject. This
may have resulted in overestimation of prevalence. Third, as
mentioned above, we could not fully explore potential sources
of heterogeneity by subgroup analyses. Fourth, as there is no
validated quality assessment tool for prevalence studies, study
quality was not formally assessed. Fifth, the included studies
investigated mainly adult male subjects. It could be possible
that male subjects were more likely to participate because of a
generally higher socioeconomic status. Because of incomplete
reporting, we could not pool data for male and female sub-
jects separately. Therefore, the results of our systematic review
TABLE 5. Subgroup Analyses.
Parameter Variablesa
Pooled prevalence of all
critical and indeterminate
incidental ﬁndings P value
Publication year Published in or after (6)










or colon MRI in the protocol




aData in parentheses are number of studies.
bOne study15 did not specify the whole-body MRI and was therefore not included in this subgroup analysis.
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and meta-analysis are only generalizable to an asymptomatic
population consisting of mainly adult male subjects.
Many people attach high value to the incidental MRI
ﬁndings of disease that "can save lives." However, there is a
need for balance between the beneﬁt and harm of whole-body
screening in asymptomatic subjects. Based on current evi-
dence, healthcare providers should not offer whole-body MRI
for preventive health screening to asymptomatic subjects out-
side of a research setting. Asymptomatic subjects undergoing
whole-body MRI should be informed about the substantial
prevalence of critical and indeterminate incidental ﬁndings,
the lack of veriﬁcation data, and the apparent substantial pro-
portion of false-positive ﬁndings.
In order to better understand the potential beneﬁt and
harms of whole-body MRI for preventive health screening, an
international consensus list of critical ﬁndings would be help-
ful for standardization and comparison of (future) study
results. Furthermore, it remains to be investigated which
whole-body MRI protocol achieves the best sensitivity and
speciﬁcity. Only a randomized trial with long-term follow-up
can deﬁnitely answer the question of whether or not whole-
body MRI for preventive health screening is beneﬁcial.
In conclusion, the prevalence of critical and indetermi-
nate incidental whole-body MRI ﬁndings in asymptomatic
subjects is overall substantial, and with variability dependent to
some degree on the protocol. Veriﬁcation data are lacking. The
proportion of false-positive ﬁndings appears to be substantial.
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